VANCOUVER, British Columbia–(GESCHÄFTSDRAHT)–PrecisionOS-Technologie (“PrecisionOS”) announced today that it has secured $2.3 million in Series A funding led by AO Invest, mit Sitz in Davos, Schweiz, zusammen mit anderen nicht genannten Investoren.

PrecisionOS bietet orthopädisch-chirurgische Ausbildung in Virtual Reality (VR). Seine Software ermöglicht es praktizierenden Chirurgen, simulierte medizinische Eingriffe in einem realistischen digitalen Operationssaal durchzuführen und bietet metrisches Feedback, um Benutzern zu helfen, ihre Techniken zu verbessern.

“PrecisionOS is delighted to be cooperating with an international organization that is a recognized leader in education for surgeons and operating room personnel around the world,” says Dr. Danny P. Goel, orthopedic surgeon, co-founder and CEO at PrecisionOS. “PrecisionOS technology is working to create a virtual language able to add depth of understanding that simply cannot be achieved using current simulation tools. Adopting VR as a way of improving decision-making is directly relevant for patients and value-based care.”

Das hervorragende Team von PrecisionOS

PrecisionOS is led by a diverse collection of individuals who are experts in their fields. Company co-founders Colin O’Connor (CTO) and Roberto Oliveira (CCO) have nearly 50 years of collective experience in the software and gaming industries. Their skill in VR development has allowed the team to create the gold standard for surgical education by building interaktive Simulationen that objectify and enhance performance. Currently a practicing surgeon as well as CEO of PrecisionOS, Dr. Goel provides insight into patients’ medical needs and helps the software target working surgeons effectively.

“VR’s ability to offer a safe environment to make mistakes is highly valuable in Chirurgen mit den Bausteinen versorgen on which to learn,” says Dr. Goel. “It allows surgeons to practice, improve their decision-making, and, importantly, have the opportunity to fail. This offers a great amount of value to our surgeons – and ultimately to our patients.”

“For all of us at AO Invest, as is the case for our partners at PrecisionOS, the patients and surgeons are always center stage: their needs are of the utmost importance to us,” said Michel Orsinger, chairman of AO Invest. “In addition to responding to requirements they have already identified, we also work to pre-empt needs that will arise as the healthcare environment changes and technology advances. We evaluated several VR companies all over the world, and PrecisionOS’s technology convinced us through its accuracy, quality, and overall approach to education in VR. The feel of the product is extremely impressive. We believe that their platform holds the potential to change surgical education and the standard of care globally.”

Looking ahead, PrecisionOS is working on developing a preoperative planning tool that allows surgeons to introduce images of a specific patient’s anatomy to the software prior to conducting a procedure.

“This area poses several challenges and novel ways to support surgeons all over the world,” says Dr. Goel. “Given our mission, we are aggressively working towards a solution to benefit the orthopedic patients of today and tomorrow.”‍

Über AO Invest:

AO Invest ist ein neu gegründeter Investmentfonds mit Fokus auf Start-ups, die im Bereich Muskel-Skelett-Erkrankungen tätig sind. Der Fonds wird unterstützt durch die AO-Stiftung, a global network of more than 19,000 surgeons and scientists in orthopedics and trauma. The goal of AO Invest is to fund start-ups related to the AO Foundation’s core expertise, and use the Foundation’s unique reach and knowledge to help their companies achieve their full potential.‍

Über PrecisionOS-Technologie:

2017 gegründet, PrecisionOS ist bestrebt, die immersivste und realistischste Form der bewussten chirurgischen Praxis anzubieten. Das Unternehmen produziert High-Fidelity-Virtual-Reality-Software für die stufenweise Ausbildung von Chirurgen und die präoperative Planung und bietet kritische chirurgische Metriken mit haptischem Feedback. PrecisionOS wurde für die Technology Impact Awards nominiert, war Halbfinalist der Orthopaedic Research Society und wurde von führenden Organisationen für orthopädische Ausbildung und Kompetenz anerkannt. PrecisionOS wird die Finanzierungserlöse verwenden, um weiterhin Vertriebspartnerschaften zu entwickeln, Inhalte für Auszubildende zu erstellen und spezialisierte VR-Ausbildungs- und präoperative Planungstools zu entwickeln.